back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-22 08:43 Tx date 2024-04-17 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-260,000
-2,000,000 vol $0.13 each |
16,289,711 | |
| Filed 2023-09-19 09:45 Tx date 2023-09-19 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-357,142 vol |
62,500 | |
| Filed 2023-09-19 09:43 Tx date 2023-09-11 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
+62,500 vol |
419,642 | |
| Filed 2023-09-19 09:30 Tx date 2023-09-11 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+125,000 vol $0.08 each |
5,888,142 | |
| Filed 2023-09-18 09:21 Tx date 2023-09-11 |
$KNE
Kane Biotech Inc. |
Renaud, Richard J.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$250,000
+2,500,000 vol $0.10 each |
4,062,500 | |
| Filed 2023-09-18 09:19 Tx date 2023-09-11 |
$KNE
Kane Biotech Inc. |
Renaud, Richard J.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$156,250
+1,562,500 vol $0.10 each |
1,562,500 | |
| Filed 2023-09-18 09:16 Tx date 2023-09-11 |
$KNE
Kane Biotech Inc. |
Renaud, Richard J.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-18 09:13 Tx date 2023-09-11 |
$KNE
Kane Biotech Inc. |
Renaud, Richard J.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250,000
+3,125,000 vol $0.08 each |
14,630,333 | |
| Filed 2023-09-18 08:56 Tx date 2023-09-11 |
$KNE
Kane Biotech Inc. |
Renaud, Richard J.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
11,505,333 | ||
| Filed 2023-09-13 10:30 Tx date 2021-12-19 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-12,571,428 vol |
0 | |
| Filed 2023-09-13 10:08 Tx date 2022-01-17 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-197,618 vol |
0 | |
| Filed 2023-09-13 10:05 Tx date 2023-09-11 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$6,250
+62,500 vol $0.10 each |
62,500 | |
| Filed 2023-09-13 09:59 Tx date 2023-09-11 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+125,000 vol $0.08 each |
985,404 | |
| Filed 2023-06-29 15:34 Tx date 2023-06-23 |
$KNE
Kane Biotech Inc. |
Morin, Georges
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+666,666 vol |
1,083,332 | |
| Filed 2023-06-29 15:31 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Morin, Georges
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+416,666 vol |
416,666 | |
| Filed 2023-06-29 14:44 Tx date 2020-05-20 |
$KNE
Kane Biotech Inc. |
Morin, Georges
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-28 22:26 Tx date 2023-06-23 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+666,666 vol |
1,788,762 | |
| Filed 2023-06-28 22:17 Tx date 2023-06-23 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,150,000 vol |
2,760,714 | |
| Filed 2023-06-27 09:52 Tx date 2023-06-23 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,675,000 vol |
4,250,000 | |
| Filed 2023-03-01 11:12 Tx date 2014-04-28 |
$KNE
Kane Biotech Inc. |
Prichard, Sarah Stobo
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-01 10:58 Tx date 2020-08-19 |
$KNE
Kane Biotech Inc. |
Prichard, Sarah Stobo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,000
+150,000 vol $0.18 each |
338,000 | |
| Filed 2021-05-13 22:11 Tx date 2020-08-19 |
$KNE
Kane Biotech Inc. |
Prichard, Sarah Stobo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,000
+150,000 vol $0.18 each |
||
| Filed 2021-05-12 20:46 Tx date 2014-04-28 |
$KNE
Kane Biotech Inc. |
Prichard, Sarah Stobo
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-19 10:01 Tx date 2022-05-16 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$310,000
+3,100,000 vol $0.10 each |
5,763,142 | |
| Filed 2022-02-04 10:53 Tx date 2022-02-04 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,250
+100,000 vol $0.1225 each |
860,404 | |
| Filed 2022-02-04 10:20 Tx date 2022-02-04 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,000
+100,000 vol $0.12 each |
2,663,142 | |
| Filed 2021-07-26 15:14 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,575,000 vol |
1,575,000 | |
| Filed 2021-07-26 15:12 Tx date 2016-06-02 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-07-26 15:11 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-1,490,000 vol |
0 | |
| Filed 2021-07-26 10:58 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+500,000 vol |
500,000 | |
| Filed 2021-07-26 10:53 Tx date 2021-05-26 |
$KNE
Kane Biotech Inc. |
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-07-26 10:41 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+847,977 vol |
847,977 | |
| Filed 2021-07-26 10:38 Tx date 2014-10-08 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-07-26 10:36 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-463,000 vol |
0 | |
| Filed 2021-07-26 10:03 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,122,096 vol |
1,122,096 | |
| Filed 2021-07-26 10:01 Tx date 2010-09-15 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-07-26 10:00 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-1,290,000 vol |
0 | |
| Filed 2021-07-26 08:56 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,610,714 vol |
1,610,714 | |
| Filed 2021-07-26 08:52 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-07-24 07:15 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
56 - Grant of rights
|
+1,610,714 vol |
||
| Filed 2021-07-22 16:47 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
56 - Grant of rights
|
+1,610,714 vol |
||
| Filed 2021-07-22 16:47 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
56 - Grant of rights
|
+1,610,714 vol |
1,610,714 | |
| Filed 2021-07-22 16:37 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-1,150,000 vol |
0 | |
| Filed 2021-05-22 13:51 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$18,000
+100,000 vol $0.18 each |
760,404 | |
| Filed 2021-05-22 12:58 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-1,928.70
-10,715 vol $0.18 each |
197,618 | |
| Filed 2021-05-22 12:57 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-16,071.30
-89,285 vol $0.18 each |
208,333 | |
| Filed 2021-05-22 12:49 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$10,000,000,000
+100,000 vol $100,000 each |
||
| Filed 2021-05-22 12:49 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$10,000,000,000
+100,000 vol $100,000 each |
760,404 | |
| Filed 2021-05-22 12:42 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-1,928.52
-10,714 vol $0.18 each |
||
| Filed 2021-05-22 12:41 Tx date 2021-05-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-16,071.48
-89,286 vol $0.18 each |
||
| Filed 2021-05-13 22:11 Tx date 2020-08-19 |
$KNE
Kane Biotech Inc. |
Prichard, Sarah Stobo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,000
+150,000 vol $0.18 each |
338,000 | |
| Filed 2021-05-12 20:46 Tx date 2014-04-28 |
$KNE
Kane Biotech Inc. |
Prichard, Sarah Stobo
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2021-04-26 09:06 Tx date 2021-04-22 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$180,000
+1,000,000 vol $0.18 each |
18,289,711 | |
| Filed 2021-04-26 08:28 Tx date 2021-04-22 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-180,000
-1,000,000 vol $0.18 each |
12,571,428 | |
| Filed 2021-03-19 15:46 Tx date 2021-03-19 |
$KNE
Kane Biotech Inc. |
Morin, Georges
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,400
+110,000 vol $0.14 each |
150,000 | |
| Filed 2021-03-19 15:43 Tx date 2020-05-20 |
$KNE
Kane Biotech Inc. |
Morin, Georges
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
40,000 | ||
| Filed 2020-12-09 17:12 Tx date 2020-12-09 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,125
+125,000 vol $0.145 each |
2,563,142 | |
| Filed 2020-12-09 14:34 Tx date 2020-12-07 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,100
+115,000 vol $0.14 each |
660,404 | |
| Filed 2020-09-29 12:30 Tx date 2020-08-19 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,800
+280,000 vol $0.16 each |
1,290,000 | |
| Filed 2020-09-29 12:24 Tx date 2020-08-19 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+150,000 vol $0.16 each |
1,150,000 | |
| Filed 2020-09-01 09:07 Tx date 2020-08-19 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+300,000 vol $0.16 each |
1,490,000 | |
| Filed 2020-06-28 19:39 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
208,333 | ||
| Filed 2020-06-28 19:31 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$2,250,000
+12,500,000 vol $0.18 each |
13,300,000 | |
| Filed 2020-06-28 19:00 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-20 10:50 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-15 15:11 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$2,250,000
+12,500,000 vol $0.18 each |
||
| Filed 2017-09-07 19:46 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-20 16:05 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$2,250,000
+12,500,000 vol $0.18 each |
||
| Filed 2020-03-07 16:13 Tx date 2020-01-12 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-35,000
-100,000 vol $0.35 each |
610,000 | |
| Filed 2020-03-07 15:56 Tx date 2020-02-28 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$72,000
+400,000 vol $0.18 each |
1,110,000 | |
| Filed 2020-03-07 15:32 Tx date 2020-02-28 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$72,000
+400,000 vol $0.18 each |
1,000,000 | |
| Filed 2020-03-03 12:54 Tx date 2020-03-02 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$108,000
+600,000 vol $0.18 each |
1,190,000 | |
| Filed 2020-03-03 12:44 Tx date 2020-03-03 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,400
+60,000 vol $0.19 each |
2,438,142 | |
| Filed 2020-03-03 12:43 Tx date 2020-03-03 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,250
+50,000 vol $0.185 each |
2,378,142 | |
| Filed 2020-03-03 12:42 Tx date 2020-03-03 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+50,000 vol $0.18 each |
2,328,142 | |
| Filed 2019-12-27 19:59 Tx date 2019-12-20 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$64,285
+357,142 vol $0.18 each |
357,142 | |
| Filed 2019-12-27 19:56 Tx date 2016-06-02 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-12-27 19:55 Tx date 2019-12-20 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$49,999
+357,142 vol $0.14 each |
2,278,142 | |
| Filed 2019-12-27 15:21 Tx date 2019-12-19 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+1,071,428 vol |
13,571,428 | |
| Filed 2019-12-27 15:18 Tx date 2019-12-19 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$299,999
+2,142,857 vol $0.14 each |
17,289,711 | |
| Filed 2019-12-27 14:56 Tx date 2019-12-19 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+89,285 vol |
297,618 | |
| Filed 2019-12-27 14:49 Tx date 2019-12-19 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$24,999
+178,571 vol $0.14 each |
545,404 | |
| Filed 2019-10-12 14:17 Tx date 2019-10-08 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,282.50
-9,500 vol $0.135 each |
600,500 | |
| Filed 2019-09-27 20:13 Tx date 2019-09-27 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-67.50
-500 vol $0.135 each |
610,000 | |
| Filed 2019-09-27 20:12 Tx date 2019-09-26 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,250
-50,000 vol $0.125 each |
610,500 | |
| Filed 2019-09-27 20:11 Tx date 2019-09-24 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,250
-10,000 vol $0.125 each |
660,500 | |
| Filed 2019-09-27 20:10 Tx date 2019-09-23 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,700
-20,000 vol $0.135 each |
670,500 | |
| Filed 2019-08-12 19:13 Tx date 2019-08-08 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,875
+75,000 vol $0.145 each |
1,921,000 | |
| Filed 2019-08-12 19:12 Tx date 2019-08-08 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,000
+100,000 vol $0.14 each |
1,846,000 | |
| Filed 2018-11-20 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-20 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
208,333 | ||
| Filed 2018-11-15 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$2,250,000
+12,500,000 vol $0.18 each |
13,300,000 | |
| Filed 2018-11-15 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$2,250,000
+12,500,000 vol $0.18 each |
||
| Filed 2018-10-31 Tx date 2018-10-25 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$17,500
+250,000 vol $0.07 each |
||
| Filed 2018-10-31 Tx date 2018-10-26 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$40,000
+500,000 vol $0.08 each |
986,000 | |
| Filed 2018-10-31 Tx date 2018-10-25 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,700
+236,000 vol $0.075 each |
486,000 | |
| Filed 2018-10-31 Tx date 2018-10-30 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,040
+100,000 vol $0.0804 each |
1,671,000 | |
| Filed 2018-10-31 Tx date 2018-10-25 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,500
+250,000 vol $0.07 each |
250,000 | |
| Filed 2018-10-31 Tx date 2018-10-25 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$17,500
+250,000 vol $0.07 each |
||
| Filed 2018-10-31 Tx date 2018-10-30 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,120
+168,000 vol $0.09 each |
1,571,000 | |
| Filed 2018-10-31 Tx date 2016-06-02 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-10-31 Tx date 2018-10-29 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,375
+275,000 vol $0.085 each |
1,403,000 | |
| Filed 2018-10-31 Tx date 2018-10-29 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,360
+142,000 vol $0.08 each |
1,128,000 | |
| Filed 2018-10-31 Tx date 2018-10-31 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,750
+75,000 vol $0.09 each |
1,746,000 | |
| Filed 2018-10-30 Tx date 2018-10-23 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,000
+350,000 vol $0.10 each |
||
| Filed 2018-10-30 Tx date 2018-10-23 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,000
+350,000 vol $0.10 each |
590,000 | |
| Filed 2018-10-29 Tx date 2018-10-23 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+150,000 vol $0.10 each |
463,000 | |
| Filed 2018-10-29 Tx date 2018-06-01 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+75,000 vol $0.20 each |
313,000 | |
| Filed 2018-10-29 Tx date 2017-07-24 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+50,000 vol $0.30 each |
238,000 | |
| Filed 2018-10-26 Tx date 2018-10-23 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,000
+100,000 vol $0.10 each |
600,000 | |
| Filed 2018-10-26 Tx date 2018-10-23 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+200,000 vol $0.10 each |
710,000 | |
| Filed 2018-10-25 Tx date 2018-10-23 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,000
+350,000 vol $0.10 each |
590,000 | |
| Filed 2018-10-25 Tx date 2018-10-25 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$17,500
+250,000 vol $0.07 each |
840,000 | |
| Filed 2018-10-22 Tx date 2018-10-22 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,972
+76,500 vol $0.065 each |
366,833 | |
| Filed 2018-07-17 Tx date 2018-07-17 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-6,500
-13,000 vol $0.50 each |
610,000 | |
| Filed 2018-07-17 Tx date 2018-07-17 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-70,000
-100,000 vol $0.70 each |
510,000 | |
| Filed 2018-06-26 Tx date 2018-06-01 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+75,000 vol $0.20 each |
240,000 | |
| Filed 2018-06-08 Tx date 2018-06-08 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+20,000 vol $0.06 each |
290,333 | |
| Filed 2018-06-08 Tx date 2018-06-06 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$720.00
+12,000 vol $0.06 each |
270,333 | |
| Filed 2018-06-01 Tx date 2018-06-01 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+200,000 vol $0.20 each |
623,000 | |
| Filed 2018-06-01 Tx date 2018-06-01 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+200,000 vol $0.20 each |
889,000 | |
| Filed 2018-06-01 Tx date 2018-05-17 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+100,000 vol $0.20 each |
||
| Filed 2018-06-01 Tx date 2018-06-01 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+100,000 vol $0.20 each |
500,000 | |
| Filed 2018-06-01 Tx date 2018-05-17 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-06-01 Tx date 2018-06-01 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
75,000 | |
| Filed 2018-05-31 Tx date 2018-05-17 |
$KNE
Kane Biotech Inc. |
Gluck, Rashieda
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
690,500 | ||
| Filed 2018-05-30 Tx date 2018-05-17 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,000
+100,000 vol $0.20 each |
500,000 | |
| Filed 2018-03-27 Tx date 2018-03-27 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,900
+20,000 vol $0.095 each |
1,294,500 | |
| Filed 2018-03-15 Tx date 2017-07-24 |
$KNE
Kane Biotech Inc. |
joshi, arvind
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+50,000 vol $0.30 each |
||
| Filed 2018-03-15 Tx date 2017-07-24 |
$KNE
Kane Biotech Inc. |
joshi, arvind
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+50,000 vol $0.30 each |
238,000 | |
| Filed 2018-03-15 Tx date 2015-01-12 |
$KNE
Kane Biotech Inc. |
joshi, arvind
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,000
+300,000 vol $0.07 each |
||
| Filed 2018-03-15 Tx date 2017-03-10 |
$KNE
Kane Biotech Inc. |
joshi, arvind
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-752,000 vol |
||
| Filed 2018-03-15 Tx date 2017-03-10 |
$KNE
Kane Biotech Inc. |
joshi, arvind
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-752,000 vol |
188,000 | |
| Filed 2018-03-15 Tx date 2016-06-21 |
$KNE
Kane Biotech Inc. |
joshi, arvind
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,300
+390,000 vol $0.07 each |
940,000 | |
| Filed 2018-03-15 Tx date 2015-01-12 |
$KNE
Kane Biotech Inc. |
joshi, arvind
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,000
+300,000 vol $0.07 each |
550,000 | |
| Filed 2018-03-15 Tx date 2016-06-21 |
$KNE
Kane Biotech Inc. |
joshi, arvind
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,300
+390,000 vol $0.07 each |
||
| Filed 2018-03-15 Tx date 2013-02-07 |
$KNE
Kane Biotech Inc. |
joshi, arvind
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,000
+250,000 vol $0.14 each |
||
| Filed 2018-03-15 Tx date 2013-02-07 |
$KNE
Kane Biotech Inc. |
joshi, arvind
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,000
+250,000 vol $0.14 each |
250,000 | |
| Filed 2018-03-12 Tx date 2018-03-09 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,550
+74,000 vol $0.075 each |
1,274,500 | |
| Filed 2018-03-06 Tx date 2017-07-24 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Notes
38 - Redemption, retraction, cancellation, repurchase
|
-$500,000 vol |
$0 | |
| Filed 2018-01-16 Tx date 2018-01-15 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,500
+50,000 vol $0.09 each |
258,333 | |
| Filed 2018-01-05 Tx date 2018-01-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,500
+100,000 vol $0.085 each |
1,200,500 | |
| Filed 2017-12-20 Tx date 2017-12-14 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50.00
+500 vol $0.10 each |
1,100,500 | |
| Filed 2017-12-08 Tx date 2017-12-08 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$12,000
+100,000 vol $0.12 each |
15,146,854 | |
| Filed 2017-11-17 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-11-17 Tx date 2017-11-14 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$120,000
+400,000 vol $0.30 each |
400,000 | |
| Filed 2017-11-17 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-07 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
208,333 | ||
| Filed 2017-09-07 Tx date 2017-09-05 |
$KNE
Kane Biotech Inc. |
Dupuis, Raymond David Eugene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
208,333 | ||
| Filed 2017-08-17 Tx date 2017-08-17 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+250,000 vol |
500,000 | |
| Filed 2017-08-17 Tx date 2017-08-17 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$30,000
+250,000 vol $0.12 each |
1,100,000 | |
| Filed 2017-08-01 Tx date 2017-07-24 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-380,000
-800,000 vol $0.475 each |
12,500,000 | |
| Filed 2017-08-01 Tx date 2017-07-24 |
$KNE
Kane Biotech Inc. |
joshi, arvind
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+50,000 vol $0.30 each |
238,000 | |
| Filed 2017-08-01 Tx date 2017-07-24 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+50,000 vol $0.30 each |
165,000 | |
| Filed 2017-08-01 Tx date 2017-07-24 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+160,000 vol $0.30 each |
689,000 | |
| Filed 2017-08-01 Tx date 2017-07-24 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+80,000 vol $0.30 each |
423,000 | |
| Filed 2017-07-20 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$2,250,000
+12,500,000 vol $0.18 each |
13,300,000 | |
| Filed 2017-07-20 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$1,500,000
+12,500,000 vol $0.12 each |
15,046,854 | |
| Filed 2017-07-20 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$45,000
+250,000 vol $0.18 each |
250,000 | |
| Filed 2017-07-20 Tx date 2015-05-11 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-20 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$30,000
+250,000 vol $0.12 each |
850,000 | |
| Filed 2017-03-28 Tx date 2017-03-28 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-8,750
-10,000 vol $0.88 each |
343,000 | |
| Filed 2017-03-28 Tx date 2017-03-28 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$12,438
+80,251 vol $0.155 each |
2,546,854 | |
| Filed 2017-03-17 Tx date 2016-06-02 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2017-03-17 Tx date 2017-03-13 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-460,000 vol |
115,000 | |
| Filed 2017-03-17 Tx date 2016-06-21 |
$KNE
Kane Biotech Inc. |
Edwards, Marc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$19,500
+325,000 vol $0.06 each |
575,000 | |
| Filed 2017-03-14 Tx date 2017-03-10 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-752,000 vol |
188,000 | |
| Filed 2017-03-14 Tx date 2016-06-21 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,300
+390,000 vol $0.07 each |
940,000 | |
| Filed 2017-03-14 Tx date 2017-03-10 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-532,000 vol |
133,000 | |
| Filed 2017-03-14 Tx date 2017-03-10 |
$KNE
Kane Biotech Inc. |
joshi, arvind
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-752,000 vol |
188,000 | |
| Filed 2017-03-14 Tx date 2016-06-21 |
$KNE
Kane Biotech Inc. |
joshi, arvind
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,300
+390,000 vol $0.07 each |
940,000 | |
| Filed 2017-03-14 Tx date 2017-03-13 |
$KNE
Kane Biotech Inc. |
Prichard, Sarah Stobo
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-752,000 vol |
188,000 | |
| Filed 2017-03-14 Tx date 2016-06-21 |
$KNE
Kane Biotech Inc. |
Prichard, Sarah Stobo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,300
+390,000 vol $0.07 each |
940,000 | |
| Filed 2017-03-13 Tx date 2017-03-13 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,412,000 vol |
353,000 | |
| Filed 2017-03-13 Tx date 2017-03-13 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-9,866,412 vol |
2,466,603 | |
| Filed 2017-03-13 Tx date 2017-03-13 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Holder: 3ELEVEN HOLDINGS LTD. (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-36,400,000 vol |
9,100,000 | |
| Filed 2017-03-13 Tx date 2017-03-13 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-2,116,000 vol |
529,000 | |
| Filed 2017-03-13 Tx date 2017-03-13 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,400,000 vol |
600,000 | |
| Filed 2017-03-13 Tx date 2017-03-13 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-3,200,000 vol |
800,000 | |
| Filed 2017-01-03 Tx date 2016-12-19 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
+251,385 vol |
12,333,015 | |
| Filed 2016-12-14 Tx date 2016-05-03 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
$-169,744.38
-5,658,146 vol $0.03 each |
0 | |
| Filed 2016-12-14 Tx date 2016-04-05 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
$169,744
+5,658,146 vol $0.03 each |
5,658,146 | |
| Filed 2016-12-14 Tx date 2010-09-15 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-14 Tx date 2016-05-03 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Holder: 3ELEVEN HOLDINGS LTD. (Control or Direction)
|
Rights
57 - Exercise of rights
|
$-682,500
-22,750,000 vol $0.03 each |
0 | |
| Filed 2016-12-14 Tx date 2016-04-05 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Holder: 3ELEVEN HOLDINGS LTD. (Control or Direction)
|
Rights
56 - Grant of rights
|
$682,500
+22,750,000 vol $0.03 each |
22,750,000 | |
| Filed 2016-12-14 Tx date 2010-09-15 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Holder: 3ELEVEN HOLDINGS LTD. (Control or Direction)
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-14 Tx date 2016-04-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights
56 - Grant of rights
|
$39,150
+1,305,000 vol $0.03 each |
1,305,000 | |
| Filed 2016-11-14 Tx date 2016-05-03 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights
57 - Exercise of rights
|
$-39,150
-1,305,000 vol $0.03 each |
0 | |
| Filed 2016-11-14 Tx date 2016-05-03 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights
57 - Exercise of rights
|
-1,305,000 vol |
||
| Filed 2016-11-14 Tx date 2016-04-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights
56 - Grant of rights
|
+1,305,000 vol |
||
| Filed 2016-11-14 Tx date 2015-05-11 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-28 Tx date 2016-09-28 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$12,830
+256,600 vol $0.05 each |
12,081,630 | |
| Filed 2016-07-07 Tx date 2016-07-07 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,000
+650,000 vol $0.06 each |
1,765,000 | |
| Filed 2016-07-07 Tx date 2016-07-07 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$12,718
+254,369 vol $0.05 each |
11,825,030 | |
| Filed 2016-06-24 Tx date 2016-06-21 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+1,495,000 vol |
2,645,000 | |
| Filed 2016-05-08 Tx date 2015-01-12 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,000
+300,000 vol $0.07 each |
550,000 | |
| Filed 2016-05-08 Tx date 2014-11-14 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,500
+250,000 vol $0.05 each |
250,000 | |
| Filed 2016-05-08 Tx date 2014-10-08 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-08 Tx date 2016-05-03 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,200
+540,000 vol $0.03 each |
665,000 | |
| Filed 2016-05-08 Tx date 2016-05-03 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+535,000 vol |
665,000 | |
| Filed 2016-05-08 Tx date 2016-04-28 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$25.00
+5,000 vol $0.005 each |
130,000 | |
| Filed 2016-05-08 Tx date 2016-04-05 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+125,000 vol $0.04 each |
125,000 | |
| Filed 2016-05-08 Tx date 2014-10-08 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-08 Tx date 2016-05-03 |
$KNE
Kane Biotech Inc. |
Nawacki, Mark Henry
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$-16,200
-540,000 vol $0.03 each |
125,000 | |
| Filed 2016-05-05 Tx date 2016-05-03 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Holder: 3ELEVEN HOLDINGS LTD. (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$682,500
+22,750,000 vol $0.03 each |
45,500,000 | |
| Filed 2016-05-05 Tx date 2016-05-03 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$169,744
+5,658,146 vol $0.03 each |
11,570,661 | |
| Filed 2016-05-04 Tx date 2016-05-03 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$50,850
+1,695,000 vol $0.03 each |
3,000,000 | |
| Filed 2016-04-08 Tx date 2016-04-07 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$12,718
+254,369 vol $0.05 each |
5,912,515 | |
| Filed 2016-04-07 Tx date 2016-04-07 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Holder: Philanderer Six Inc. (Control or Direction)
|
Common Shares
97 - Other
|
-22,750,000 vol |
0 | |
| Filed 2016-04-07 Tx date 2016-04-07 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Holder: 3ELEVEN HOLDINGS LTD. (Control or Direction)
|
Common Shares
97 - Other
|
+22,750,000 vol |
22,750,000 | |
| Filed 2016-04-07 Tx date 2010-09-15 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Holder: 3ELEVEN HOLDINGS LTD. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-16 Tx date 2016-02-16 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+20,000 vol $0.05 each |
1,305,000 | |
| Filed 2016-01-05 Tx date 2016-01-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$92,000
+1,150,000 vol $0.08 each |
1,150,000 | |
| Filed 2016-01-05 Tx date 2015-05-11 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-05 Tx date 2016-01-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,950
+39,000 vol $0.05 each |
1,285,000 | |
| Filed 2015-12-15 Tx date 2013-12-18 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$380,000
+4,000,000 vol $0.095 each |
5,250,000 | |
| Filed 2015-12-15 Tx date 2013-12-18 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$380,000
+4,000,000 vol $0.095 each |
||
| Filed 2015-12-15 Tx date 2013-12-18 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Notes
11 - Acquisition or disposition carried out privately
|
$
+$500,000 vol $1.00 each |
$500,000 | |
| Filed 2015-12-15 Tx date 2013-12-18 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Notes
11 - Acquisition or disposition carried out privately
|
$
+$500,000 vol $1.00 each |
||
| Filed 2015-11-05 Tx date 2015-11-04 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Holder: Philanderer Six Inc. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
-5,000,000 vol |
0 | |
| Filed 2015-11-05 Tx date 2015-11-04 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Holder: Philanderer Six Inc. (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$300,000
+5,000,000 vol $0.06 each |
22,750,000 | |
| Filed 2015-11-04 Tx date 2015-11-04 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,250
+50,000 vol $0.065 each |
1,246,000 | |
| Filed 2015-10-05 Tx date 2015-10-02 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,840
+96,000 vol $0.04 each |
1,196,000 | |
| Filed 2015-09-24 Tx date 2015-09-22 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$12,708
+254,178 vol $0.05 each |
5,658,146 | |
| Filed 2015-08-24 Tx date 2015-08-21 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Holder: Philanderer Six Inc. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-300,000
-5,000,000 vol $0.06 each |
5,000,000 | |
| Filed 2015-08-24 Tx date 2015-08-21 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Holder: Philanderer Six Inc. (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$300,000
+5,000,000 vol $0.06 each |
17,750,000 | |
| Filed 2015-07-24 Tx date 2015-07-24 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,465
+99,000 vol $0.035 each |
1,100,000 | |
| Filed 2015-07-24 Tx date 2015-07-24 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30.00
+1,000 vol $0.03 each |
1,001,000 | |
| Filed 2015-07-08 Tx date 2015-07-08 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+150,000 vol $0.04 each |
1,000,000 | |
| Filed 2015-06-29 Tx date 2015-06-25 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$12,708
+254,178 vol $0.05 each |
5,403,968 | |
| Filed 2015-06-26 Tx date 2015-06-26 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+150,000 vol $0.035 each |
850,000 | |
| Filed 2015-06-19 Tx date 2015-06-19 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+200,000 vol $0.04 each |
700,000 | |
| Filed 2015-06-10 Tx date 2015-06-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,220
+316,000 vol $0.045 each |
500,000 | |
| Filed 2015-06-10 Tx date 2015-06-05 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,360
+184,000 vol $0.04 each |
184,000 | |
| Filed 2015-06-10 Tx date 2015-05-11 |
$KNE
Kane Biotech Inc. |
Ahrens-Townsend, Mark William
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2014-01-24 Tx date 2014-01-23 |
$KNE
Kane Biotech Inc. |
Froehlich, Gordon John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-22,500
-150,000 vol $0.15 each |
0 | |
| Filed 2014-01-24 Tx date 2014-01-23 |
$KNE
Kane Biotech Inc. |
Froehlich, Gordon John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$22,500
+150,000 vol $0.15 each |
1,219,429 |